Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-24-000722
Filing Date
2024-02-14
Accepted
2024-02-14 14:06:29
Documents
55
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nbio_10q.htm   iXBRL 10-Q 599152
2 CERTIFICATION nbio_ex311.htm EX-31.1 11055
3 CERTIFICATION nbio_ex312.htm EX-31.2 11099
4 CERTIFICATION nbio_ex321.htm EX-32.1 3583
5 CERTIFICATION nbio_ex322.htm EX-32.2 4135
  Complete submission text file 0001477932-24-000722.txt   3303774

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nbio-20231231.xsd EX-101.SCH 50362
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20231231_lab.xml EX-101.LAB 254208
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20231231_cal.xml EX-101.CAL 32472
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20231231_pre.xml EX-101.PRE 202593
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20231231_def.xml EX-101.DEF 109256
57 EXTRACTED XBRL INSTANCE DOCUMENT nbio_10q_htm.xml XML 365211
Mailing Address 631 US HWY 1, SUITE 407 NORTH PALM BEACH FL 33408
Business Address 631 US HWY 1, SUITE 407 NORTH PALM BEACH FL 33408 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

EIN.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-55299 | Film No.: 24635897
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)